Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic and Geron Extend Oligo Manufacturing Licensing Agreement

NEW YORK, June 4 - Transgenomic and Geron announced today an expanded non-exclusive licensing agreement covering the manufacture of oligonucleotides.


Transgenomic of Omaha, Neb., extends a license to manufacture phosphoramidate-based oligos based on the patented processes acquired by Menlo Park, Calif.-based Geron from Lynx Therapeutics in 2002. The company will pay undisclosed royalties on the sales of diagnostic and therapeutic products, as well as on those products for research use.


Phosphoramidate-based oligos are synthetic nucleic acids.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.